LifeLens Technologies Expands Executive Leadership Team and Board of Directors
08 Novembre 2023 - 1:30PM
LifeLens Technologies, Inc. (LifeLens), a medical technology
company that provides real-time physiological monitoring, today
announced the appointment of three industry veterans to the
following positions on its executive leadership team and Board of
Directors:
- Daniel J. Sullivan, Chairman of the Board of LifeLens, as Chief
Executive Officer
- Brent A. Moen as Chief Financial
Officer
- Richard J. Buchholz as a member of
the Board of Directors
“With LifeLens, we have a significant
opportunity to disrupt healthcare and make a meaningful impact on
patients and healthcare professionals, and we are thrilled to have
Brent and Rick join the LifeLens team,” said Dan Sullivan, Chief
Executive Officer and Chairman of the Board of Directors of
LifeLens. “Brent and Rick collectively bring over 60 years of
combined experience and track records that have led to business
growth while transforming clinical care, and now their skills will
help enable LifeLens to realize its potential.”
Daniel Sullivan has served as Chairman of the
Board of Directors of LifeLens and assumed the additional role of
Chief Executive Officer of LifeLens effective January 2023. Mr.
Sullivan brings over 40 years of leadership in the medical device
industry where he has been a principal, chief executive officer,
board member or co-founder of 11 separate start-up companies, 10 of
which have been acquired. These companies include SciMed Life
Systems, Inc., which was acquired by Boston Scientific Corporation
in 1995, The WATCHMAN (Atritech, Inc.), which was acquired by
Boston Scientific Corporation in 2011, superDimension, Ltd., which
was acquired by Covidien plc in 2012 and NeuWave Medical, Inc.,
which was acquired by Johnson & Johnson in 2016.
Brent Moen was appointed to the position of
Chief Financial Officer effective September 2023 and has over 30
years of experience in finance. Mr. Moen most recently served as
the Chief Financial Officer of Tactile Systems Technology,
Inc. (Nasdaq: TCMD), a publicly traded medical device company,
from September 2018 until March 2023. Prior to joining
Tactile Systems Technology, Mr. Moen served as Chief Financial
Officer of Entellus Medical, Inc., a publicly traded medical device
company, from 2016 until its acquisition by Stryker
Corporation in 2018. Mr. Moen also served as the Chief
Financial Officer of ABRA Auto Body & Glass LP, as well as
the Chief Financial Officer of Regis Corporation.
Richard Buchholz was appointed to the LifeLens’
Board of Directors, effective October 2023. Since 2014, Mr.
Buchholz has served as the Chief Financial Officer of Inspire
Medical Systems, Inc. (NYSE: INSP), a global leader in the
development and commercialization of innovative, minimally invasive
solutions for patients with obstructive sleep apnea. Prior to
joining Inspire, Mr. Buchholz served as the Chief Financial
Officer at superDimension, Ltd. from 2006 to 2013. Mr. Buchholz
also served as the Chief Financial Officer of Vascular Solutions,
Inc., which was acquired by Teleflex Incorporated in 2017.
About LifeLens Technologies,
Inc.
LifeLens, a private healthcare company, has
developed a revolutionary system incorporating artificial
intelligence capable of monitoring physiological data to assess
real-time health readiness and performance. The LifeLens system can
provide monitoring both remotely and, in the hospital, or doctors’
office and can wirelessly transmit real‐time scenarios providing
actionable information that will allow health professionals to make
data-driven decisions to improve the health and welfare of
patients. The LifeLens product is FDA-cleared for the indication of
remote single channel electrocardiogram (ECG) and heart rate
monitoring. The system is not yet FDA cleared for other
indications.
Since 2019, LifeLens has been testing its
wearable physiological sensors with the United States Armed Forces,
allowing military leaders the ability to monitor their troops
health, readiness, and performance in real-time training and
operational environments. For more information, please visit
www.lifelenstech.com.
Inquiries:
Dan Sullivan, CEOdsullivan@lifelenstech.com
Brent Moen, CFObmoen@lifelenstech.com
Grafico Azioni Tactile Systems Technology (NASDAQ:TCMD)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Tactile Systems Technology (NASDAQ:TCMD)
Storico
Da Nov 2023 a Nov 2024